Product Information
LETROZOLE 2.5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1511 per EA under NDC 59651018030. Its NADAC has been published 354 times since Nov 13, 2019.
FDA first approved this application on Jan 11, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651018030
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LETROZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA211717FDA Approved
1/11/2019
TE Code
AB
On Market Since
1/11/2019
Pharmacological Classes
Price Statistics
The NADAC for LETROZOLE 2.5 MG TABLET has been published 354 times since Nov 13, 2019, and over the history we have for it it has risen 11.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1511 per EA |
|---|---|
| All-time high | $0.1535 (Jul 15, 2026) |
| All-time low | $0.1009 (Jun 21, 2023) |
| 52-week high | $0.1535 |
| 52-week low | $0.1292 |
| Median price | $0.1406 |
| Average price | $0.1356 |
| Largest weekly change | +32.3% (Nov 22, 2023) |
| Weeks tracked | 354 |
| Tracking since | Nov 13, 2019 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LETROZOLE 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LETROZOLE 2.5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.1511 per EA (NDC 59651018030), effective Aug 19, 2026.
How has the price of LETROZOLE 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for LETROZOLE 2.5 MG TABLET has risen 11.0%. It has been tracked across 354 weekly CMS publications since Nov 13, 2019.
What are the highest and lowest recorded NADAC prices for LETROZOLE 2.5 MG TABLET?
Since Nov 13, 2019, the NADAC for LETROZOLE 2.5 MG TABLET has ranged from a low of $0.1009 (Jun 21, 2023) to a high of $0.1535 (Jul 15, 2026), with a median of $0.1406 per EA.
Are there cheaper alternatives to LETROZOLE 2.5 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LETROZOLE 2.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LETROZOLE 2.5 MG TABLET?
LETROZOLE 2.5 MG TABLET (NDC 59651018030) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.